Which patients with ischaemic heart disease could benefit from cell replacement therapy?

European Heart Journal, Supplement

Volumn 8, Issue H, 2006, Pages

  Lipiecki, Janusz ^a   Durel, Nicolas ^a   Ponsonnaille, Jean ^a  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

Author keywords

Cell replacement therapy; Heart failure; Left ventricular remodelling

Indexed keywords

ALDOSTERONE RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CONTRAST MEDIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RECEPTOR BLOCKING AGENT;

ACUTE HEART INFARCTION; ARTICLE; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CELL TRANSPLANTATION; CONTRAST ECHOCARDIOGRAPHY; DEFIBRILLATOR; DIAGNOSTIC ACCURACY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FIBRINOLYTIC THERAPY; GENETIC PREDISPOSITION; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; HUMAN; ISCHEMIC HEART DISEASE; LONG TERM CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT ELEVATION;

EID: 33845950262     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sul062     Document Type: Article

References (41)

1. Strauer BE, Brehm M, Zeus T, Köstering M, Hernandez A, Sorg RV, Kögler G, Wernet P. Repair of infracted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-1918.
2. Assmus B, Schächinger V, Teupe C, Britten M, Lehman R, Döbert N, Grünwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher A. Transplantation of Progenotor cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation 2002;106:3009- 3017.
3. Ripa RS, Jorgensen E, Wang Y, Thune JJ, Nilsson JC, Sondergaard L, Johnsen HE, Kober L, Grande P, Kastrup J. Stem cells mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction. Results of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 2006;113:1983-1992.
4. Perin E, Dohman HFR, Borojevic R, Silva S, Sousa ALS, Mesquita CT, Rossi MID, Carvalho A, Dutra HS, Dohman HJF, Silva GV, Belém L, Vivacqua R, Rangel FOD, Esporcatte R, Geng YJ, Vaughn WK, Assad J, Mesquita ET, Willerson JT. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischaemic heart failure. Circulation 2003;107:2294-2302.
5. Menasché P, Hagège AA, Vilquin J-T, Desnos M, Abergel E, Pouzet B, Bel A, Sarateanu S, Scorsin M, Schwartz K, Bruneval P, Benbunan M, Marolleau J-P, Duboc D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003;41:1078-1083.
6. Siminiak Fiszer D, Jerzykowska O, Grygielska B, Rozwadowska N, Kalmucki P, Kurpisz M. Percutaneous trans-coronary-venous transplantation of autologous skeletal myoblastes in the treatment of post-infarction myocardial contractility impairment. Poznan Trial Eur Heart J 2005;26:1189-1195.
7. Smits PC, van Geuns R-JM, Poldermans D, Bontioukos M, Ondewater EEM, Lee CH, Maat APWM, Serruys PW. Catheter-based intramyocardial injection of autologous skeletal myoblastes as a primary treatment of ischaemic heart failure. J Am Coll Cardiol 2003;42:2063-2069.
8. St John Sutton M, Pfeffer MA, Moye L, Plappert T, Rouleau JL, Lamas G, Rouleau J, Parker JO, Arnold MO, Sussex B, Braunwald E. Cardiovascular death and left ventricular remodeling two years after myocardial infarction. Baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial. Circulation 1997;96:3294-3299.
9. Doughty RN, Whalley GA, Walsh HA, Gamble GD, Lopez-Sendon J, Sharpe N. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction. The CAPRICORN echo substudy. Circulation 2004;109:201- 206.
10. Hudson MP, Amstrong PW, Ruzyllo W, Brum J, Cusmano L, Krzeski P, Lyon R, Quinones M, Theroux P, Sydlowski D, Kim HE, Garcia MJ, Jaber WA, Weaver WD. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction. J Am Coll Cardiol 2006;48:15-20.
11. Bolognese L, Neskovic AN, Parodi G, Cerisano G, Buonamici P, Santoro GM, Antoniucci D. Left ventricular remodeling after primary coronary angioplasty. Patterns of left ventricular dilation and long-term prognosis implications. Circulation 2002;106:2351-2357.
12. Cerisano G, Domenico P, Valenti R, Boddi V, Migliorini A, Tommasi MS, Raspanti S, Parodi G, Antoniucci D. Comparison of the usefulness of Doppler-derived deceleration time versus plasm brain natriuretic peptide to predict left ventricular remodeling after mechanical revascularization in patients with ST-elevation acute myocardial infarction and left ventricular systolic dysfunction. Am J Cardiol 2005;95:930-934.
13. Husic M, Norager B, Egstrup K, Moller JE. Usefulness of left ventricular diastolic wall motion abnormality as an early predictor of left ventricular dilation after a first acute myocardial infarction. Am J Cardiol 2005;96:1186-1189.
14. Mengozzi G, Rossini R, Palagi C, Musumeci G, Petronio AS, Limbruno U, Caravelli P, Di Bello V, Mariani M. Usefulness of intravenous myocardial contrast echocardiography in the early left ventricular remodeling in acute myocardial infarction. Am J Cardiol 2002;90:713-719.
15. Lipiecki J, Cachin F, Durel N, de Tauriac O, Ponsonnaille J, Maublant J. Influence of infarct-zone viability detected by rest Tc-99 m sestamibi gated SPECT on left ventricular remodeling after acute myocardial infarction treated by percutaneous transluminal coronary angioplasty in the acute phase. J Nucl Cardiol 2004;11:673-681.
16. Bigi R, Mafrici A, Colombo P, Gregori D, Corrada E, Alberti A, De Biase A, Orrego PS, Fiorentini C, Klugman S. Relation of terminal QRS distortion to left ventricular functional recovery and remodeling in acute myocardial infarction treated with primary angioplasty. Am J Cardiol 2005;96:1233-1236.
17. Mattichak SJ, HArjai KJ, Dutcher JR, Boura JA, Stone G, Cox D, Brodie BR, O'Neill WO, Grines CL. Left ventricular remodeling and systolic deterioration in acute myocardial infarction: findings from the Stent-PAMI study. J Interv Cardiol 2005;18:255-260.
18. De Kam PJ, Nicolosi GL, Voors AA, van den Berg MP, Brouver J, van Veldhuisen DJ, Barlera S, Maggioni AP, Gianuzzi P, Temorelli PL, Latini R, van Gilst WH. Prediction of 6 months left ventricular dilatation after myocardial infarction in relation to cardiac morbidity and mortality. Eur Heart J 2002;23:536-542.
19. De Lemos JA, Braunwald E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol 2001;38:1283-1294.
20. Nicolau JC, Maia LN, Vitola J, Vaz VD, Machado MN, Godoy MF, Giraldez RR, Ramirez JA. St-segment resolution and late (6-month) left ventricular remodeling after acute myocardial infarction. Am J Cardiol 2003;91:451-453.
21. Ujino K, Hillis GS, Mulvagh SL, Hagen ME, Oh JK. Usefulness of real-time intravenous myocardial contrast echocardiography in predicting left ventricular dilatation after successfully reperfused acute myocardial infarction. Am J Cardiol 2005;96:17-21.
22. Bolognese L, Carraba N, Parodi G, Santoro GM, Buonamici P, Cerisano G, Antoniucci D. Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 2004;109:1121-1126.
23. Cerisano G, Domenico P, Valenti R, Boddi V, Migliorini A, Tommasi MS, Raspanti S, Parodi G, Antoniucci D. Comparison of the usefulness of Doppler-derived deceleration time versus plasm brain natriuretic peptide to predict left ventricular remodeling after mechanical revascularization in patients with ST-elevation acute myocardial infarction and left ventricular systolic dysfunction. Am J Cardiol 2005;95:930-934.
24. Mannaerts HFJ, van der Heide JA, Kamp O, Stoel MG, Twisk J, Visser CA. Early identification of left ventricular remodelling after myocardial infarction, assessed by transthoracic 3D echocardiography. Eur Heart J 2004;25:680-687.
25. Hombach V, Grebe O, Merkle N, Waldenmaier S, Höher M, Kochs M, Wöhrle J, Kestler HA. Sequelae of acutemyocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005;26:549-557.
26. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-1321.
27. Samady H, Elefteriades JA, Abott BG, Mattera JA, McPherson CA, Wackers FJTh. Failure to improve left ventricular function after coronary revascularization for ischaemic cardiomyopathy is not associated with worse outcome. Circulation 1999;100:1298-1304.
28. Lee KS, Marwick TH, Cook SA, Go RT, Fix JS, James KB, Sapp SK, MacInery WJ, Thomas JD. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687- 2694.
29. Bax JJ, Visser FC, Poldermans D, Elhendy A, Cornel JH, Boersma E, Valkema R, van Lingen A, Fioretti PM, Visser CA. Relationship between preoperative viability and postoperaitive improvement in LVEF and heart failure symptoms. J Nucl Med 2001;42:79-86.
30. Schinkel AFL, Bax JJ, Boersma E, Elhendy A, Roelandt JRTC, Poldermans D. How many patients with ischaemic cardiomyopathy exhibit viable myocardium? Am J Cardiol 2001;88:561-564.
31. Bax JJ, Schinkel AFL, Boersma E, Elhendy A, Rizello V, Maat A, Roelandt JRTC, van der Wall EE, Poldermans D. Extensive left ventricular remodeling does not allow viable myocardium to improve in left ventricular ejection fraction after revascularization and is associated with worse long-term prognosis. Circulation 2004;110:II18-II22.
32. Schinkel AFL, Poldermans D, Rizello V, Vanoverschelde J-L J, Elhendy A, Boersma E, Roelandt JRTC, Bax JJ. Why do patients with ischaemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization? J Thorac Cardiovasc Surg 2004;127:385- 390.
33. Bax JJ, Poldermans D, Elhendy A, Cornel JH, Boersma E, Rambaldi R, Roelandt JRTC, Fioretti P. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999;34:163-169.
34. Dor V, Di Donato M, Sabatier M, Civaia F. Other surgical or devicebased approaches to treating cardiac remodeling. In: Greenberg B, ed. Cardiac Remodeling Mechanism and Treatment. New York, London: Taylor & Francis; 2006.
35. Ribeiro GCA, Antonialli F, Lopes MM, Costa CE, Albuquerque AN, Franchini KG. Left ventricular reconstruction brings benefit for patients with ischaemic cardiomyopathy. J Cardiac Fail 2006;12:189-194.
36. Ratcliffe MB. The treatment of ischaemic heart failure with surgical ventricular restoration (SVR): new evidence of benefit. J Cardiac Fail 2006;12:195-198.
37. Goldenberg I, Moss AJ, Hall WJ, McNitt S, Zareba W, Andrews ML, Cannom DS. Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Automatic defibrillator Implantation Trial II. Circulation 2006;113:2810-2817.
38. Freemantle N, Tharmanathan P, Calvert MJ, Abraham WT, Ghosh J, Cleland JGF. Cardiac resynchronization for patients with heart failure due to left ventricular systolic dysfunction - a systematic review and meta-analysis. Eur J Heart Fail 2006;8:433-440.
39. Kass DA. Ventricular remodeling: chamber dyssynchrony and effects of cardiac resynchronization. Eur Heart J 2003;5(Suppl. I):I54-I63.
40. Duncan A, Wait D, Gibson D, Daubert J-C. Left ventricular remodelling and haemodynamic effects of multisite biventricular pacing in patients with left ventricular systolic dysfunction and activation disturbances in sinus rhythm: sub-study of the MUSTIC (Multisite Stimulation in Cardiomyopathies) trial. Eur Heart J 2003;24:430-441.
41. McAlister FA, Tu JV, Newman A, Lee A, Lee DS, Kimber S, Cujec B, Amstrong PW. How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts. Eur Heart J 2006;27:323-329.